MPG.eBooks - Table of Contents: Pharmacoeconomic review report: Preservative-free latanoprost 50 [mu]g/mL ophthalmic solution (Monoprost) (Laboratoires Théa)

Read Now

Pharmacoeconomic review report: Preservative-free latanoprost 50 [mu]g/mL ophthalmic solution (Monoprost) (Laboratoires Théa)

Preservative-free latanoprost (Monoprost) is available as a sterile ophthalmic solution in a single-dose container (50 mcg/mL). Health Canada approved Monoprost for the reduction of intraocular pressure (IOP) in patients with ocular hypertension (OH) or open-angle glaucoma (OAG). The manufacturer is...

Full description

Bibliographic Details
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) CADTH 2018, May 2018
Series:	CADTH common drug review
Subjects:	Canada Ocular Hypertension / Drug Therapy Latanoprost / Therapeutic Use Glaucoma, Open-angle / Drug Therapy Cost-benefit Analysis Latanoprost / Economics
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK533372
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Table of Contents:

Includes bibliographical references

Pharmacoeconomic review report: Preservative-free latanoprost 50 [mu]g/mL ophthalmic solution (Monoprost) (Laboratoires Théa)

Similar Items